Skip to main content
Clinical Trials/CTRI/2025/01/078931
CTRI/2025/01/078931
Completed
Not Applicable

Intraoperative Fluid Therapy-Finding A Balance: A Single Centre Experience With Restrictive Fluid Therapy In Adult Living Donor Liver Transplant

Dr Amit Singhal1 site in 1 country200 target enrollmentStarted: January 28, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Dr Amit Singhal
Enrollment
200
Locations
1
Primary Endpoint
•Incidence of Acute kidney injury within 72 hours postoperatively. Need for renal replacement therapy.

Overview

Brief Summary

We practice weight based restrictive fluid strategy with maintenance therapy at 4ml/kg/h (2ml/kg/h crystalloids + 2ml/kg/h 4%albumin solution) and fluid boluses guided by goal directed parameters.We will retrospectively analyze our data of patients undergoing adult living donor liver transplant in one year period and determine the average fluid requirement and its effect on pulmonary outcomes and incidence of postoperative acute kidney injury. Secondary outcomes will be intraoperative blood and vasopressor requirement(noradrenaline) and vascular complication rate.We hypothesise that our strategy of continuous maintenance therapy with intermittent fluid boluses improves pulmonary outcomes with no increased risk of acute kidney injury. The statistical analysis will be done with the Graph Pad Prism.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All patients over 18years of age undergoing adult living donor liver transplant from December 2022 to November 2023 will be enrolled in the study.

Exclusion Criteria

  • Patients less than 18years of age.
  • Patients with H/O recent (less than one week) Hepatorenal syndrome/Acute Kidney Injury.
  • Patients with known H/O chronic kidney disease.
  • Patients with Hepatopulmonary syndrome/Portopulmonary Hypertension.
  • Combined procedure with liver transplant.
  • H/O hepatic encephalopathy (Grade 2 or more at the time of transplant).
  • Patients with acute liver failure. INTRAOPERATIVE-.
  • Patients requiring intraoperative continuous renal replacement therapy.
  • Patients with incomplete data POSTOPERATIVE.
  • Patient requiring mechanical ventilation for graft dysfunction or neurological complications.

Outcomes

Primary Outcomes

•Incidence of Acute kidney injury within 72 hours postoperatively. Need for renal replacement therapy.

Time Frame: 72 hours

•Evaluate our rate of early extubation (on-table extubation, extubated within 4hours postoperatively) after living donor liver transplant, mean duration of mechanical ventilation, pulmonary complications such as pulmonary edema , pleural effusion requiring drainage within 72 hours postoperatively.

Time Frame: 72 hours

Secondary Outcomes

  • Intraoperative need for packed red blood cells, vasopressor requirement (noradrenaline-mcg/kg/min and total vasopressin units) and rate of vascular complications (hepatic artery thrombosis)(Intraoperative period)

Investigators

Sponsor
Dr Amit Singhal
Sponsor Class
Other [Non funded study]
Responsible Party
Principal Investigator
Principal Investigator

Dr Amit Singhal

BLK Max Superspeciality Hospital

Study Sites (1)

Loading locations...

Similar Trials